Medicine prices, availability, and affordability in 36 developing and middle-income countries: a secondary analysis.

No abstract is available for this paper.

• Publication year

  2009

• Venue

  The Lancet

• Publication date

  2009-01-17

• Fields of study

  Medicine, Business, Economics

• Identifiers
  DOI 10.1016/S0140-6736(08)61762-6PMID 19042012
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Price differentiation and transparency in the global pharmaceutical marketplace

  2012cited by this paper
• [Diabetes care in sub-Saharan Africa].

  2007cited by this paper
• Evaluating Drug Prices, Availability, Affordability, and Price Components: Implications for Access to Drugs in Malaysia

  2007cited by this paper
• The availability and affordability of selected essential medicines for chronic diseases in six low- and middle-income countries.

  2007cited by this paper
• Price, availability and affordability. An international comparison of chronic disease medicines

  2006cited by this paper
• Diabetes care in sub-Saharan Africa.

  2006cited by this paper
• The pricing and procurement of antiretroviral drugs: an observational study of data from the Global Fund.

  2006cited by this paper
• The World Health Report 2000

  2002cited by this paper
• International price comparisons for pharmaceuticals. Measurement and policy issues.

  1998cited by this paper
• Public-private roles in the pharmaceutical sector. Implications for equitable access and rational drug use

  1997cited by this paper
• Methodological Aspects of International Drug Price Comparisons

  1993cited by this paper

• Global mechanisms to improve affordability of high-priced medicines: the role of the WHO model lists of essential medicines

  2026cites this paper
• Assessing the national essential medicines list selection processes: Instrument development and testing.

  2026cites this paper
• Access to Essential Medicines in Low- and Middle-Income Countries: A Systematic Review of Barriers and Facilitators

  2026influential citation
• Retail Sales of Drugs for Diabetes, Dyslipidemia, and Hypertension in Chile Under 2 Health Policies.

  2026cites this paper
• The triple burden: A systematic review and meta-analysis of essential medicine availability, price, and affordability across Ethiopian health facilities

  2025cites this paper
• Longitudinal Trends in Medicine Supply, Price and Utilisation in Primary Care Facilities in Rural Southwestern China Under National Essential Medicines Policy (2012-2017): Disparities Across Facilities and Medicines

  2025cites this paper
• International Experience in the Management of Pharmaceutical Expenditure: A Narrative Literature Review.

  2025cites this paper
• Centralized procurement authority and corporate innovation

  2025cites this paper
• Bridging the Regulatory Divide: A Dual-Pathway Framework Using SRA Approvals and AI Evaluation to Ensure Drug Quality in Developing Countries

  2025cites this paper
• Monitoring essential medicines access-unfinished business.

  2025cites this paper
• The availability of drugs for stable COPD treatment in China: a cross-sectional survey

  2025cites this paper
• Revolutionising cancer treatment access in low-income and middle-income countries: a sustainable approach.

  2025cites this paper
• Impact of China's National Drug Price Negotiation Policy on Availability, Affordability, and Regional Equity of Negotiated Drugs: A Multidimensional Nationwide Analysis, 2018 - 2021.

  2025cites this paper
• Benefits, challenges, and best practices of collaborative partnerships among health supply chain stakeholders in Rwanda: a cross-sectional study

  2025cites this paper
• Adherence to asthma and COPD inhaled therapies in low- and middle-income countries: a narrative review

  2025cites this paper
• Antidiabetic drug utilization pattern, affordability and cost analysis in Iran from 2009 to 2021: A need to revise guideline

  2025cites this paper
• Paediatric neurological care in Sub-Saharan Africa: Current status and future directions.

  2025cites this paper
• Comprehensive review of pharmaceutical waste: Environmental and health impacts, management strategies using 3R principles, and future implications

  2025cites this paper
• Logics of acquiring medicines from informal retailers in four African countries

  2025cites this paper
• Impact of national volume-based procurement reform on the markup of pharmaceutical firms: an event study

  2025cites this paper
• Facility readiness and experience of women and health care providers in receiving and delivering obstetric care in comprehensive health posts in Ethiopia: a mixed method study

  2025cites this paper
• Availability, pricing, and affordability of antithrombotic medicines in Addis Ababa, Ethiopia: implications for health policy

  2025cites this paper
• Prices of Anti-Diabetic Drugs Sold in Private Pharmacies in Côte d’Ivoire, 2023: A Secondary Analysis

  2025cites this paper
• Prices and Affordability of Essential Medicines in 72 Low-, Middle-, and High-Income Markets

  2025cites this paper
• Patients Satisfaction Towards Services of Primary Health Centres

  2025cites this paper
• Availability, prices and affordability of self-monitoring blood glucose devices: surveys in six low-income and middle-income countries

  2025cites this paper
• Time and cost involved in measuring access to medicines: the case of Albania

  2025cites this paper
• Electronic data sources for drug utilization research and healthcare decision-making in Mexico

  2025cites this paper
• The path to performance of public versus private healthcare supply chains: case study of Uganda

  2025cites this paper
• Prices, availability, and affordability of adult medicines in 54 low-income and middle-income countries: evidence based on a secondary analysis.

  2025cites this paper
• Key stakeholders’ views on the causes of medicine stock-outs in Mauritania: A qualitative study

  2025cites this paper
• Availability, affordability, and associated factors of essential medicines in primary health care facilities of the Wolaita zone, southern Ethiopia: implication for access, a cross-sectional study, 2022

  2025influential citation
• Quality and Cost-Effectiveness in Pharmaceutical Procurement: Strategies and a Systematic Review

  2025cites this paper
• Prices, availability, and affordability of selected medicines for asthma management in Nigeria: a nationwide study

  2025influential citation
• Pharmaceutical expenditure changes under the volume-based procurement policy: Effects and influencing factors

  2025cites this paper
• Availability and affordability of antidiabetic medicines in Herat of Afghanistan in 2023

  2024cites this paper
• Addressing the asthma crisis in Africa: challenges, strategies, and recommendations for improved management

  2024cites this paper
• Availability, prices, and affordability of essential medicines in Asia: A systematic review

  2024cites this paper
• Faith-based Pharmaceutical Supply Chains and their Role in African Pharmaceutical Systems: A Qualitative Systematic Review

  2024cites this paper
• Review of public health commodity distribution models in Nigeria

  2024cites this paper
• Improving access to medicines to reduce marketing and use of substandard and falsified medicines in Africa: Scoping review

  2024cites this paper
• Resource shortage in public health facilities and private pharmacy practices in Odisha, India

  2024cites this paper
• Evaluation of Seven Different Brands of Metformin Hydrochloride Tablets Available in the Market in Gondar City, Ethiopia

  2024cites this paper
• Geospatial Pharmacy Navigator: A Web and Mobile Application Integrating Geographical Information System (GIS) for Medicine Accessibility

  2024cites this paper
• A systematic scoping review of medicine availability and affordability in Africa

  2024cites this paper
• Reducing Pharmaceutical and Non-Pharmaceutical Inventory Waste in Tertiary Hospital: Impact of ABC-VEN Analysis in a Zero-Waste Strategy Over 7 Years

  2024cites this paper
• A Brief Review on Essential Medicine

  2024cites this paper
• Testing the unintended cost effects of health policies for generic substitutions: the case of China’s National Volume-Based Procurement (NVBP) policy

  2024cites this paper
• Reducing the Travel Burden for Patients to Access Specialized Medicines in Paraná, Brazil.

  2024cites this paper
• Exploring access to essential medicines in the South Pacific: insights from a multi-country cross-sectional study

  2024cites this paper
• Biochemical Pathophysiology of Hypertension: Nursing Interventions in Blood Pressure Regulation and Treatment

  2024cites this paper
• Examining malaria treatment and prevention spending efficiency in malaria-endemic countries, 2000–2020

  2024cites this paper
• Strengthening regulation for medical products in Tanzania: An assessment of regulatory capacity development, 1978–2020

  2024cites this paper
• The Availability of Essential Antimicrobials in Public and Private Sector Facilities: A Cross-Sectional Survey in a District of North India

  2024influential citation
• Physicians and the Production of Health: Returns to Health Care During the Mortality Transition

  2024cites this paper
• Availability, price, and affordability of diabetes mellitus and thyroid dysfunction medicines in South Wollo zone, Northeast Ethiopia

  2024influential citation
• Public entry and private prices: New evidence from Indian pharmaceutical markets

  2024cites this paper
• Unveiling the unseen toll: exploring the impact of the Lebanese economic crisis on the health-seeking behaviors in a sample of patients with diabetes and hypertension

  2024cites this paper
• Audit of essential medicine listing and registration status of medicines on standard treatment guidelines in Kenya, Tanzania and Uganda: Case study of malaria, tuberculosis, hypertension and type 2 diabetes mellitus

  2024cites this paper
• Antidiabetic potential of sea fish mass by inhibiting di-peptidyl peptidase-IV and augmenting glucagon-like peptide-1 on high lipid diet and streptozotocin induced diabetic rats

  2024cites this paper
• Availability and stock‐outs of paediatric antiretroviral treatment formulations at health facilities in Kenya and Uganda

  2024cites this paper
• Availability, price, and affordability of anti-hepatitis B virus drugs: a cross-sectional study in China

  2024cites this paper
• Availability and Price Variations of Commonly Used Cardiovascular Medicines at Community and Hospital Pharmacies in Gondar Town, Northwest Ethiopia

  2024cites this paper
• Access to essential medicines used in the management of noncommunicable diseases in Southern Ethiopia: Analysis using WHO/HAI methodology

  2024cites this paper
• Inequalities in disease burden and care quality of chronic obstructive pulmonary disease, 1990–2021: Findings from the Global Burden of Disease Study 2021

  2024cites this paper
• Challenges and the Way Forward in Demand-Forecasting Practices within the Ethiopian Public Pharmaceutical Supply Chain

  2024cites this paper
• Low- And Middle-Income Countries Experienced Delays Accessing New Essential Medicines, 1982-2024.

  2024cites this paper
• Resistome in a changing environment: Hotspots and vectors of spreading with a focus on the Russian-Ukrainian War

  2024cites this paper
• Primary health care as the main guarantor of a healthy population in the country and a global challenge in the world: a systematic review

  2024cites this paper
• Relationship between Prices and Quality of Essential Medicines from Different Manufacturers Collected in Cameroon, the Democratic Republic of the Congo, and Nigeria

  2024cites this paper
• Suitability of paediatric legislation beyond the USA and Europe: a qualitative study on access to paediatric medicines

  2024cites this paper
• Promouvoir l'accès aux technologies médicales et l'innovation, deuxième édition

  2023cites this paper
• Editorial: Medication safety and interventions to reduce patient harm in low- and middle-income countries

  2023cites this paper
• Case assessment and identification of pharmaceutical supply chain performance measures and metrics

  2023cites this paper
• Access to Essential Medicines and Diagnostic Tests for Cardiovascular Diseases in Maputo City, Mozambique

  2023cites this paper
• The role of the private sector in noncommunicable disease prevention and management in low- and middle-income countries: a series of systematic reviews and thematic syntheses

  2023influential citation
• A socio-ecological framework examination of drivers of blood pressure control among patients with comorbidities and on treatment in two Nairobi slums; a qualitative study

  2023cites this paper
• The Global Landscape on the Access to Cancer Medicines for Breast Cancer: The ONCOLLEGE Experience.

  2023cites this paper
• Overcoming Barriers to Generic Drug Adoption: Insights from Global Studies

  2023cites this paper
• Medicine shortages: impact behind numbers

  2023cites this paper
• Last-mile distribution and commodity availability, security and access: the moderating role of supply chain integration

  2023cites this paper
• Costing Interventions for Developing an Essential Package of Health Services: Application of a Rapid Method and Results From Pakistan

  2023cites this paper
• Evaluating the affordability of asthma, chronic obstructive pulmonary disease, and cystic fibrosis medicines in a middle-income country

  2023cites this paper
• Role of health literacy and primary health-care access in self-care management of hypertension

  2023cites this paper
• The pan-Canadian Tiered Pricing Framework and Chinese National Volume-Based Procurement: A comparative study using Donabedian’s structure-process-outcome framework

  2023cites this paper
• ASSESSMENT OF THE STATUS OF TUBERCULOSIS MULTIDRUG-RESISTANCE (MDR-TB) IN ABU-ANGA TB REFERENCE HOSPITAL, SUDAN 2015 - 2021

  2023cites this paper
• Perceived health system facilitators and barriers to integrated management of hypertension and type 2 diabetes in Kenya: a qualitative study

  2023cites this paper
• Sources of Uncertainty and Risk Quantification Methods in Supply Chain Management: A Literature Study

  2023cites this paper
• Economic analysis of allogeneic hematopoietic stem cell transplantation in the Bone Marrow Transplant Center of Tunisia

  2023cites this paper
• Improving the availability of antihypertensive drugs in the India Hypertension Control Initiative, India, 2019–2020

  2023cites this paper
• Willingness to pay brand premiums for generic medicines in Kenya: A bidding game experiment.

  2023cites this paper
• A quasi-experimental study of the volume-based procurement (VBP) effect on antiviral medications of hepatitis B virus in China

  2023cites this paper
• Accessibility crisis of essential medicines at Sudanese primary healthcare facilities: a cross-sectional drugs’ dispensaries assessment and patients’ perspectives

  2023cites this paper
• A national survey on registered products, availability, prices, and affordability of 100 essential medicines in community pharmacies across Sri Lanka

  2023cites this paper
• Readiness of health facilities to provide services related to non-communicable diseases in Nepal: evidence from nationally representative Nepal Health Facility Survey 2021

  2023cites this paper
• Challenges to the Availability and Affordability of Essential Medicines in African Countries: A Scoping Review

  2023cites this paper
• Scenario-Based Optimization of Supply Chain Performance under Demand Uncertainty

  2023cites this paper
• Optimizing Antibacterial Activity of Psidium guajava Extracts using Solvent Fractionation method and its Efficacy against Foodborne Pathogens

  2023cites this paper
• An Assessment of the Availability of Essential Medicines in Gadag Taluk, Karnataka: A Study of Primary Health Centers

  2023influential citation
• Affordability of newer antiseizure medications in Asian resource‐limited countries

  2023cites this paper